| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000272077.1 |
Ponatinib |
Brain lower grade glioma |
0.041819866 |
Resistant |
| ENSG00000272077.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016785886 |
Sensitive |
| ENSG00000272077.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.006381132 |
Resistant |
